MicroSteer

Endoscopic Add-on Device for the Removal of Complex Lesions

Health Tech & Life Sciences
Active
Pre-Seed Nazareth, Israel Founded 2023
Last updated 2026-06-18
Total raised
Last: 2023-01
Stage
Pre-Seed
Founded
2023
Headcount
4
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences

About

MicroSteer is developing a robotic system for endoscopic removal of complex GI tumors, avoiding open or laparoscopic surgeries. MicroSteer’s device is the first steered polypectomy device, enabling endoscopists a safer and faster procedure, currently executed only by highly experienced interventional gastroenterologists or surgeons.

Funding history · 1 round · — total

2023-01
Undisclosed

Q&A

What is MicroSteer's primary focus?
MicroSteer is developing a robotic system for the endoscopic removal of complex GI tumors, aiming to avoid open or laparoscopic surgeries.
When was MicroSteer founded?
MicroSteer was founded in January 2023.
What is the current employee count for MicroSteer?
MicroSteer has 4 employees, falling within the 1-10 employee bucket.
What is MicroSteer's current funding stage?
MicroSteer is currently in the Pre-Seed funding stage.
Which investor participated in MicroSteer's January 2023 funding round?
NGT HealthCare II participated in MicroSteer's funding round in January 2023.
What is MicroSteer's primary sector?
MicroSteer's primary sector is Health Tech & Life Sciences.
Does MicroSteer hold any patents?
Yes, MicroSteer holds 1 patent.
Where is MicroSteer's headquarters located?
MicroSteer's headquarters is located in Nazareth, Israel.

Team · 2

Founder · Founder
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

cancermedical-deviceshealthcareendoscopygastroenterology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)